News
-
20 September 2021
New drug combination shows promise for ovarian cancer patients in early trial
A new combination of ovarian cancer drugs that shrinks low-grade serous ovarian cancer tumours has shown promising results in early clinical trials.
-
18 July 2021
Protect the vulnerable as Covid-19 restrictions lift, urges cancer charities
From Monday 19th July, people are no longer required to wear face masks in crowded places or maintain social distance. While this will be a relief to many, it means that cancer patients - who are more at-risk from the virus and less protected by the vaccine than the general public - may feel they are once again unable to enjoy normal daily life and socialise safely.
-
16 July 2021
WI members pass resolution to increase awareness of ovarian cancer symptoms
200,000 members of the Women’s Institute will mobilise and campaign for better awareness amongst those at risk of ovarian cancer and health professionals.
-
11 June 2021
What is the national ovarian cancer audit?
With the UK’s ovarian cancer survival rates remaining some of the lowest in Europe, our Head of Public Affairs and Research looks at the game-changing announcement of a government-funded ovarian cancer audit, what this means for women with ovarian cancer, and how you helped us get there.
-
11 June 2021
NHS England announces national ovarian cancer audit
NHS England have confirmed that the future of the ovarian cancer audit is secure, with the announcement that it is one of five new cancer audits to be commissioned by the Healthcare Quality Improvement Partnership (HQIP).
-
13 May 2021
What has happened to the worlds largest ovarian cancer screening trial?
Researchers at University College London have found that these screening approaches did not significantly reduce the chance of these women developing late stage ovarian cancer. Unfortunately, this means that these tests cannot be recommended as a screening programme for the public.
-
10 May 2021
-
19 March 2021
NICE approves a new combination of treatment for women with advanced ovarian cancer
Today the National Institute for Health and Care Excellence (NICE) has announced a new maintenance treatment option for women with HRD positive advanced ovarian cancer in England. The new treatment is a welcome addition to a growing number of targeted therapy options that will help women with advanced ovarian cancer live longer.
-
01 March 2021
It’s Ovarian Cancer Awareness Month and we’re putting the spotlight on age inequality
Over 7,000 women are diagnosed with ovarian cancer each year, with more than a third over the age of 70. Yet, in the first of a series of reports highlighting inequalities in ovarian cancer, women over 70 are not receiving the standard of care necessary to survive ovarian cancer.
-
26 February 2021
Julia Bradbury is Ovarian Cancer Action's new charity ambassador
On 31st January Julia presented Ovarian Cancer Action’s BBC Lifeline Appeal. In her own words, Julia explains why she has chosen to support them in her new role as charity ambassador.
-
28 January 2021
Ovarian Cancer Action's BBC Lifeline Appeal
Getting the nation's eyes on ovarian cancer. Julia Bradbury presents Ovarian Cancer Action's BBC Lifeline Appeal.
-
15 January 2021
Niraparib - the latest treatment option for women with ovarian cancer in England
Today, women diagnosed with advanced ovarian cancer will have access to a life-extending drug called Niraparib, thanks to the National Institute for Health and Care Excellence (NICE).
-
14 January 2021
New classification system “Oxford Classic” can create accurate predictions of ovarian cancer outcomes
Ovarian Cancer Action funded researcher, Professor Ahmed Ahmed, from the University of Oxford Weatherall Institute, is already making several exciting breakthroughs with his research - in more areas than one.
-
16 December 2020
The BioIndustry Association announces 2021 charity partnership with Ovarian Cancer Action
Ovarian Cancer Action is proud to announce that it is the BioIndustry Association’s (BIA) chosen charity partner for 2021.
-
30 November 2020
-
27 November 2020
Tampon Tax Fund awards Ovarian Cancer Action over £1m to tackle health inequalities
Today the ovarian cancer audit feasibility pilot published its latest findings on the variation in ovarian cancer treatment across England - revealing significant regional differences in access to ovarian cancer treatment (particularly surgery) across the country.
-
25 November 2020
Amazon Prime film release focuses on ovarian cancer, featuring Cara Delevingne
In a first for Amazon Prime, Life in a Year is a film that focuses on a young girl with ovarian cancer. This film is particularly important because it is so rare that ovarian cancer is mentioned in the mainstream media, and even less so as a concern for younger women.
-
11 November 2020
Differences in treatment revealed in new report
Today the ovarian cancer audit feasibility pilot published its latest findings on the variation in ovarian cancer treatment across England - revealing significant regional differences in access to ovarian cancer treatment (particularly surgery) across the country.
-
02 November 2020
New research confirms the importance of CA125 blood tests in diagnosing ovarian cancer in primary care
A team of researchers at the University of Cambridge, Manchester and Exeter are the first to provide evidence that the already established CA125 blood test for ovarian cancer is an effective diagnostic tool in the primary care setting.
-
28 October 2020
